Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RAFA will - over the next 2 Weeks and hit - by . In that time frame, RAFA's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
RAFA shares fell -7.69% in Friday, September 11, 2026's trading session, dropping from a previous close of $0.03 to move at $0.02. The stock demonstrated notable intraday movement (see RAFA's key stats for a full breakdown), fluctuating between $0.02 and $0.02, a 0 trading range. While recent weeks have seen some volatility, RAFA has managed to secure a +26.25% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 8K shares changing hands, 18K fewer than the previous session. This amounted to $192.00 in total market activity.
Will RAFA Continue Its Trend?
According to analyst ratings and projections for RAFA, Rafarma Pharmaceuticals, Inc. shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for RAFA currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 18 negative trading days within the past 30 sessions. Based on the RAFA stock forecast, now is not the best time to buy RAFA stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on RAFA covering social and institutional perspectives.
RAFA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RAFA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 24.27% to 39.59%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 44.28%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.44%, maintains a neutral outlook for the long term. Insights into RAFA's shareholder base show how institutional investors are positioning themselves during these momentum shifts

